119 related articles for article (PubMed ID: 3464352)
1. Teniposide and cytarabine combination chemotherapy in the treatment of relapsed adolescent and adult acute lymphoblastic leukemia.
Sanz GF; Sanz MA; Rafecas FJ; Martínez JA; Martín-Aragonés G; Marty ML
Cancer Treat Rep; 1986 Nov; 70(11):1321-3. PubMed ID: 3464352
[TBL] [Abstract][Full Text] [Related]
2. Treatment of refractory acute lymphoblastic leukemia with teniposide and cytarabine.
Kamen BA; Casper J; Lauer S; Camitta BM; Holcenberg JS
Cancer Treat Rep; 1986 Jul; 70(7):935-6. PubMed ID: 3459577
[No Abstract] [Full Text] [Related]
3. [VM-26 and cytosine arabinoside in the treatment of acute refractory lymphoblastic leukemia in adults].
Marín P; Grañena A; Carreras E; Sierra J; Olivé MT; Rozman C
Sangre (Barc); 1984; 29(4-A):399-404. PubMed ID: 6594782
[No Abstract] [Full Text] [Related]
4. Phase II evaluation of teniposide and ifosfamide in refractory adult acute lymphocytic leukemia: a Southwest Oncology Group Study.
Ryan DH; Kopecky KJ; Head D; Gumbart CN; Grever MR; Karanes C; Weick JK; Coltman CA
Cancer Treat Rep; 1987; 71(7-8):713-6. PubMed ID: 3475171
[TBL] [Abstract][Full Text] [Related]
5. [Acute lymphoblastic leukemia of high risk: results of a therapeutic protocol].
Castel V; Verdeguer A; Ferris J; Esquembre C
An Esp Pediatr; 1987 Nov; 27(5):331-4. PubMed ID: 3481522
[TBL] [Abstract][Full Text] [Related]
6. A single high dose of idarubicin combined with high-dose ARA-C (MSKCC ALL-3 protocol) in adult and pediatric patients with acute lymphoblastic leukemia. Experience at the University "La Sapienza" of Rome.
Testi AM; Moleti ML; Giona F; Annino L; Chiaretti S; Del Giudice I; Todisco E; D'Elia G; Ferrari A; Arcese W; Mandelli F
Haematologica; 1997; 82(6):664-7. PubMed ID: 9499665
[TBL] [Abstract][Full Text] [Related]
7. Teniposide plus cytarabine improves outcome in childhood acute lymphoblastic leukemia presenting with a leukocyte count greater than or equal to 100 x 10(9)/L.
Dahl GV; Rivera GK; Look AT; Hustu HO; Kalwinsky DK; Abromowitch M; Mirro J; Ochs J; Murphy SB; Dodge RK
J Clin Oncol; 1987 Jul; 5(7):1015-21. PubMed ID: 3474355
[TBL] [Abstract][Full Text] [Related]
8. High-dose idarubicin in combination with Ara-C in patients with relapsed or refractory acute lymphoblastic leukemia: a pharmacokinetic and clinical study.
Tedeschi A; Montillo M; Strocchi E; Cafro AM; Tresoldi E; Intropido L; Nichelatti M; Marbello L; Baratè C; Camaggi CM; Morra E
Cancer Chemother Pharmacol; 2007 May; 59(6):771-9. PubMed ID: 17256136
[TBL] [Abstract][Full Text] [Related]
9. VM-26 and cytarabine combination chemotherapy in refractory or relapsed adult acute lymphoblastic leukemia.
Carella AM; Santini G; Martinengo M; Giordano D; Nati S; Congiu A; Risso M; Vimercati R; Cerri R; Rossi E
Haematologica; 1984; 69(6):747-51. PubMed ID: 6441752
[No Abstract] [Full Text] [Related]
10. rHuGM-CSF after high-dose chemotherapy in post-remission acute leukemia.
Hurtado R; Candelaria M; Vargas F; Majluf A; Bolaños F; Labardini JR
Stem Cells; 1995 Mar; 13(2):112-22. PubMed ID: 7787778
[TBL] [Abstract][Full Text] [Related]
11. [Effect of modified FLAG regimen therapy on 33 patients with relapsed/refractory leukemia].
Meng FY; Yang LJ; Xu B; Liu XL; Zheng WY; Zhang Y; Huang F; Sun J; Liu QF
Ai Zheng; 2003 Dec; 22(12):1330-3. PubMed ID: 14693062
[TBL] [Abstract][Full Text] [Related]
12. High rate of long-term survival in adult acute leukemia following ten-day chemotherapy (OAP) induction. Maintenance with chemotherapy or chemotherapy plus BCG vaccine.
Hewlett JS; Chen T; Balcerzak SP; Gutterman JU; Costanzi JJ; Amare M
Arch Intern Med; 1985 Jun; 145(6):1006-12. PubMed ID: 3890786
[TBL] [Abstract][Full Text] [Related]
13. IDA-FLAG regimen for the therapy of primary refractory and relapse acute leukemia: a single-center experience.
Yavuz S; Paydas S; Disel U; Sahin B
Am J Ther; 2006; 13(5):389-93. PubMed ID: 16988532
[TBL] [Abstract][Full Text] [Related]
14. Teniposide (VM-26) and ara-C in the treatment of adult acute lymphoblastic leukemia.
Linker CA; Levitt LJ; O'Donnell M; Ries CA; Forman SJ
Semin Oncol; 1987 Jun; 14(2 Suppl 1):78-85. PubMed ID: 3473686
[No Abstract] [Full Text] [Related]
15. Efficacy of liposomal daunorubicin and cytarabine as reinduction chemotherapy in relapsed acute lymphoblastic leukaemia despite expression of multidrug resistance-related proteins.
Candoni A; Michelutti A; Simeone E; Damiani D; Baccarani M; Fanin R
Eur J Haematol; 2006 Oct; 77(4):293-9. PubMed ID: 16856922
[TBL] [Abstract][Full Text] [Related]
16. Phase II study of mitoxantrone and cytarabine in acute myeloid leukemia.
Brito-Babapulle F; Catovsky D; Slocombe G; Newland AC; Marcus RE; Goldman JM; Galton DA
Cancer Treat Rep; 1987 Feb; 71(2):161-3. PubMed ID: 3467843
[TBL] [Abstract][Full Text] [Related]
17. Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
Haematologica; 1999 Mar; 84(3):226-30. PubMed ID: 10189387
[TBL] [Abstract][Full Text] [Related]
18. Teniposide in the treatment of leukemia: a case study of conflicting priorities in the development of drugs for fatal diseases.
Grem JL; Hoth DF; Leyland-Jones B; King SA; Ungerleider RS; Wittes RE
J Clin Oncol; 1988 Feb; 6(2):351-79. PubMed ID: 3276827
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy in relapsed childhood acute lymphoblastic leukemia.
Amato KR; Sallan SE; Lipton JM
Cancer Treat Rep; 1984 Feb; 68(2):411-2. PubMed ID: 6583001
[TBL] [Abstract][Full Text] [Related]
20. High-dose Ara-C plus VM-26 in adult acute lymphoblastic leukemia.
Larson RA; Gaynor ER; Shepard KV; Daly KM
Eur J Cancer Clin Oncol; 1985 Oct; 21(10):1261-3. PubMed ID: 3865776
[No Abstract] [Full Text] [Related]
[Next] [New Search]
